
Image via NVIDIA
Sunday, September 20, 2026
Meta kills AI photo @-mentions after backlash
Meta killed its controversial AI photo feature that let users @-mention people in generated images after talent agencies pushed back. Meanwhile, an AI agent built its own inference infrastructure in weeks at GLM, showing early signs of recursive self-improvement.

Image via NVIDIA
Top Stories
TechCrunch
Meta quickly pulled an AI photo-referencing feature from its new Muse Image generator after backlash over non-consensual use concerns, highlighting persistent challenges in deploying AI tools responsibly on social platforms.
Anthropic
Anthropic's new Life Sciences Verification Program enables verified researchers to use Claude models with customized, permissive safeguards for biology and drug discovery work, balancing research enablement with biosecurity through behavioral monitoring and tiered access controls.
Z.ai
Z.ai deployed GLM-5.3-Flash using an AI agent to build production inference infrastructure on 100,000+ Chinese accelerators, achieving 3x performance gains in under two weeks. The work demonstrates early recursive self-improvement capabilities where AI models optimize the systems that run themselves, though human oversight remains critical for objectives and risk assessment.
newsletter.pragmaticengineer.com
OpenAI has become fully dependent on Codex agents for virtually all work, with 90% adoption across non-engineering teams and a 10x increase in code output per engineer. The company has built an automated 'software factory' where agents handle code generation, review, deployment, and production monitoring, fundamentally changing traditional software engineering practices and tooling.
Typesafe AI
TypeSafe AI launched Jev, a specialized AI model optimized for structured decisions and automation workflows rather than text generation, delivering 100-444x improvements in speed and cost over traditional LLMs while eliminating hallucinations through mathematical guarantees.
Keep Reading
Industry Voices
Dario Amodei
Co-founder and CEO at Anthropic
Posts detailed technical breakdowns of AI safety research and shares Anthropic's thinking on scaling laws before they become industry consensus.
Mike Doustdar
President and CEO at Novo Nordisk
Offers insights on how AI is transforming drug discovery and clinical trials in diabetes and obesity treatments at the world's leading metabolic disease company.
Enjoyed this issue?
Get daily AI intel delivered to your inbox. No fluff, just the stories that matter.